From animal tissue to engineered cells: biotechnological advances in sulfated glycosaminoglycan production
Current Opinion in Biotechnology · 2025
DOI: 10.1016/j.copbio.2025.103340 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2025. Verfasst von Aditi Dey Tithi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, United States; Department of Chemical and B…. Hauptthemen laut MEDLINE: Glycosaminoglycans, Biotechnology, Metabolic Engineering, Cell Engineering. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Biotechnological strategies are rapidly advancing the production of sulfated glycosaminoglycans (GAGs), such as chondroitin sulfate and heparin, offering animal-free alternatives with greater safety and structural control. This article examines key developments across microbial, enzymatic, and synthetic platforms, highlighting innovations in metabolic engineering, sulfotransferase optimization, and cofactor regeneration. Case studies in both chondroitin and heparin biosynthesis illustrate how systems biology and protein design are addressing long-standing bottlenecks. We also discuss current limitations and future directions needed to realize scalable, clinically relevant GAG bioproduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, United States; Department of Chemical and Biological Engineering, Troy, NY, United States.
- Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, United States.
- Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, United States; Department of Chemical and Biological Engineering, Troy, NY, United States. Electronic address: ko…
Förderung
- National Science Foundation
Zitieren
APA
Tithi, A. D., Song, Y., Zeghal, H., & Koffas, M. (2025). From animal tissue to engineered cells: biotechnological advances in sulfated glycosaminoglycan production. Current Opinion in Biotechnology. https://doi.org/10.1016/j.copbio.2025.103340
Vancouver
Tithi AD, Song Y, Zeghal H, Koffas M. From animal tissue to engineered cells: biotechnological advances in sulfated glycosaminoglycan production. Current Opinion in Biotechnology. 2025. doi:10.1016/j.copbio.2025.103340
BibTeX
@article{Tithi2025,
author = {Tithi, Aditi Dey and Song, Yuefan and Zeghal, Hana and Koffas, Mattheos},
title = {From animal tissue to engineered cells: biotechnological advances in sulfated glycosaminoglycan production},
journal = {Current Opinion in Biotechnology},
year = {2025},
doi = {10.1016/j.copbio.2025.103340}
}
EUVIMED